| WHO | World Health Organization |
| APA | Advance Purchase Agreement |
| AMC | Advanced Market Commitment |
| US | United States of America |
| VCR | Vaccine Coverage Rate |
| WHA | World Health Assembly |
| TB | Tuberculosis |
| HIV | Human Immunodeficiency Virus |
| NCD | Non-Communicable Disease |
| PIVI | Partnership for International Vaccine Initiatives |
| PPP | Public–Private Partnership |
| IVAC | Institute of Vaccine and Medical Biologicals |
| PDP | Product Development Partnership |
| OECD | Organization for Economic Cooperation and Development |
| BARDA | Biomedical Advanced Research and Development Authority |
| CEPI | Coalition for Epidemic Preparedness Innovations |
| NIAID/NIH | National Institute of Allergy and Infectious Disease/ National Institute for Health |
| HHS | Health and Human Services |
| FDA | Food and Drug Administration |
| CDC | Center for Disease Control |
| BLSS | Biomanufacturing and Life Science Strategy |
| HERA | Health Emergency Preparedness and Response Authority |
| H/L/MIC | High/Middle/Low Income Country |
| RVMC | Regional Vaccine Manufacturing Collaborative |
| PAVM | Partnerships for African Manufacturing |
| DPA | Defense Prevention Act |
| WTO | World Trade Organization |
| PIP | Pandemic Influenza Preparedness |
| PC | Partnership Contribution |
| ANVISA | Brazilian Health Regulatory Agency |
| PAHO | Pan American Health Organization |
| GISRS | Global Influenza Surveillance Response System |
| HLIP | High Level Implementation Plan |
| HCW | Healthcare Workers |
| SAMRC | South African Medical Research Council |
| KPI | Key Performance Indicator |